98 related articles for article (PubMed ID: 26305424)
1. Hepatic radiofrequency ablation causes an increase of circulating histones in patients with hepatocellular carcinoma.
Gu T; Ge Y; Song Y; Fu Z; Zhang Y; Wang G; Shao S; Wen T
Scand J Clin Lab Invest; 2015 Nov; 75(7):621-7. PubMed ID: 26305424
[TBL] [Abstract][Full Text] [Related]
2. Impact of Elevated Circulating Histones on Systemic Inflammation after Radiofrequency Ablation in Lung Cancer Patients.
Gu T; Wen T; Zhang Y; Zhang D; Hua H; Liu L; Zhang Y; Fu Z; Yuan Z
Biomed Res Int; 2017; 2017():6894832. PubMed ID: 29457035
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of circulating histones indicate disease activity in patients with hand, foot, and mouth disease (HFMD).
Li X; Li Q; Li J; Li Y; Chen Y; Lv A; Zhang J; Ding J; Von Maltzan K; Wen T
Scand J Infect Dis; 2014 Dec; 46(12):818-24. PubMed ID: 25195650
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
Jiang T; Zhang X; Ding J; Duan B; Lu S
Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
[TBL] [Abstract][Full Text] [Related]
5. Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors.
Jansen MC; van Wanrooy S; van Hillegersberg R; Rijken AM; van Coevorden F; Prevoo W; van Gulik TM
Eur J Surg Oncol; 2008 Jun; 34(6):662-7. PubMed ID: 17892922
[TBL] [Abstract][Full Text] [Related]
6. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation.
Simo KA; Sereika SE; Newton KN; Gerber DA
J Surg Oncol; 2011 Dec; 104(7):822-9. PubMed ID: 21520094
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
9. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
[TBL] [Abstract][Full Text] [Related]
10. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
11. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.
Fang Y; Chen W; Liang X; Li D; Lou H; Chen R; Wang K; Pan H
J Gastroenterol Hepatol; 2014 Jan; 29(1):193-200. PubMed ID: 24224779
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of indocyanine green retention rate with respect to complications of radiofrequency ablation in 878 patients with hepatocellular carcinoma.
Tang T; Feng X; Yan J; Xia F; Li X; Ma K; Bie P
Int J Hyperthermia; 2014 Sep; 30(6):402-7. PubMed ID: 25256893
[TBL] [Abstract][Full Text] [Related]
13. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
Ziol M; Sutton A; Calderaro J; Barget N; Aout M; Leroy V; Blanc JF; Sturm N; Bioulac-Sage P; Nahon P; Nault JC; Charnaux N; N'kontchou G; Trinchet JC; Delehedde M; Seror O; Beaugrand M; Vicaut E; Ganne-Carrié N
J Hepatol; 2013 Dec; 59(6):1264-70. PubMed ID: 23928407
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2012 Mar; 27(3):553-61. PubMed ID: 21913982
[TBL] [Abstract][Full Text] [Related]
16. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
19. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
Cho HJ; Kim SS; Ahn SJ; Park SY; Park JH; Kim JK; Wang HJ; Cheong JY; Cho SW
Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190
[TBL] [Abstract][Full Text] [Related]
20. Case study of hepatic radiofrequency ablation causing a systemic inflammatory response under total intravenous anesthesia.
Schälte G; Henzler D; Waning C; Tacke J; Rossaint R; Mahnken AH
Korean J Radiol; 2010; 11(6):640-7. PubMed ID: 21076590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
